To map out genomic differences between highly pathogenic Yersinia enterocolitica WA-314C biogroup 1B, serotype O:8 strain and lowpathogenic Y. enterocolitica Y-108C biogroup 4, serotype O:3 strain we have applied a method of suppression subtractive hybridization (SSH). In total, 428 WA-314-specific and 83 Y-108-specific sequences were uncovered by SSH. Among them were DNA fragments with similarity to known genes from several groups: (1) genes involved in O-antigen biosynthesis, (2) host-specific restriction-modification systems, (3) systems of iron and heme acquisition and storage, (4) flagellar biogenesis genes, (5) putative virulence factors, (6) drug resistance genes, and (7) mobile elements. Mapped out genomic differences may be applied in identification and development of novel therapeutic strategies for the treatment of enteropathogenic Yersinia.
Introduction
The human pathogen Yersinia enterocolitica forms two evident groups, one consisting of the mouse-virulent strains (biogroup ( 21) while the other group contains strains that are avirulent to mice in low doses [6] . Moreover, mouse-lethal strains, in contrast to their non-lethal counterparts, are more destructive in humans and cause extensive ulceration of the gastrointestinal tract and even death [4] . The ability to produce the siderophore yersiniabactin might be one of the important virulence traits supplying BG 1B strains with iron that is necessary to establish an infection [20] . On the other hand, predominantly low-virulent siderophore-negative Y. enterocolitica ST (O:3, O:9, O:5,27) have been recovered from patients with transfusion-associated bacteremia [3] . Also post-yersinial secondary sequelae are mostly associated with Y. enterocolitica O:3 infections [12] . Nosocomial infections with Y. enterocolitica O:9 have been documented, but also strains belonging to normally avirulent serobiotypes such as O:5, BG 1A or O:6,30, BG 1A may cause an infection [3, 24] . Thus, serotype-, biogroup-or even strain-speci¢c markers might be responsible for the noted di¡erences in clinical manifestations of yersiniae. To map out such lineage-speci¢c markers, we applied the suppression subtractive hybridization (SSH) method. This method was successfully used for the identi¢cation of genomic di¡erences between Y. enterocolitica WA-314C BG 1B, ST O:8 and Y. enterocolitica NF-O BG 1A, ST O:5 [10] . Therefore, a mouselethal Y. enterocolitica BG 1B, ST O:8 was used both as a tester and as a driver in SSH with a mouse non-virulent Y. enterocolitica BG 4, ST O:3 strain to uncover gene acquisitions and losses in both strains of the selected pair. , and Escherichia coli JM109 were obtained from the strain collection of the Max von Pettenkofer-Institut. Typically, bacterial strains were cultured on Luria^Bertani medium at 27 ‡C for Yersinia strains, and at 37 ‡C for E. coli strain.
Molecular biology techniques
Bacterial DNA was isolated with the Nucleobond AXG Kit (Macherey-Nagel, Germany) according to the manufacturer's instructions. SSH [8] was performed with the Clontech PCR-Select Bacterial Genome Subtraction Kit (Clontech Laboratories, USA). Generation of the subtracted library was achieved by transformation of the highly e⁄cient JM109 cells with pMOSBlue vectors carrying various subtracted fragments. The subtraction e⁄-ciency was determined by Southern blot and colony blot hybridizations as previously described [2] . Sequencing was performed on ABI 377 Sequencer (Applied Biosystems) and by Agowa, Berlin, as part of a co-operation within the Pathogenomics Network. Analysis of sequences was carried out with the BLAST program from NCBI and the TIGR-CMR program.
Results and discussion
To uncover genomic di¡erences between mouse virulent and mouse non-virulent human pathogenic yersiniae, we subtracted genomic DNA of the mouse virulent WA-314C, BG 1B, ST O:8 strain with genomic DNA of mouse non-virulent Y-108C, BG 4, ST O:3 strain using WA-314C strain ¢rst as a tester and than as a driver. Both, O:8-and O:3-speci¢c sequences were recognized in hybridization. Only DNA fragments with possible impact on virulence and those, which can serve as epidemiological markers are depicted in Tables 1 and 2 . The percentages of clones in the subtracted libraries that correspond to testerspeci¢c DNA were 53% and 49% for O:8 and O:3, respectively. In total, 428 O:8-speci¢c and 83 O:3-speci¢c sequences were identi¢ed. Not surprisingly, 60% of O:8-and 44% of O:3-speci¢c sequences showed high similarity (70^95%) to the sequences of the completed Yersinia pestis CO92 genome (Tables 1 and 2) .
Genes involved in synthesis of O:3-speci¢c (wbbX, wbbW, and wbbT) [31] and O :8-speci¢c (fcl, manC, and wbcG) [32] O-antigens, as well as host-speci¢c restriction [28] , and ShuA outer membrane heme receptor of Shigella dysenteriae [16] . Certain candidates for virulence factors were revealed in both strains. Sequences with similarity to RtxA-like cytotoxin of Vibrio cholerae [13] , type III secretion system of Salmonella typhimurium located on a SPI2 pathogenicity island (YscT, SseD, and SscA) [18, 7] , Xnp2 nematocidal toxin from Xenorhabdus [17] , or YapA and YapG putative autotransporter proteins from Y. pestis [19] , were speci¢c for Y. enterocolitica O:3. Surprisingly, sequences with similarity to the proteins of the chromosomally encoded type III secretion system (TTSS) were more closely related to the putative proteins YPO0272, YPO0261, YPO0262 and YPO0263 of the Y. pestis CO92 than to the TTSS of Y. enterocolitica O:8 strain 8081 [9] . On the other hand, sequences with similarity to putative HlyD secretion protein YPO2999 from Y. pestis [19] , adenylate cyclase [21] , Pic protease with mucinase and hemagglutinin activities from Shigella £exneri [1] , or CNF cytotoxic necrotizing factor found in Yersinia pseudotuberculosis [14] turned out to be Y. enterocolitica O:8-speci¢c sequences.
Strains of both serotypes contain sequences that might be involved in drug resistance. VCA0253 streptogramin A acetyltransferase from V. cholerae [27] and putative multidrug resistance protein from Aeromonas hydrophila [33] were revealed in Y. enterocolitica O :3 strain, while three proteins, YPO1267, a probable drug-resistant translocator protein, YPO3268, multidrug resistance protein B, and YPO3133, multidrug e¥ux protein from Y. pestis [19] , were speci¢c for Y. enterocolitica O:8. SSH readily mapped known Y. enterocolitica 1B-speci¢c insertion sequences such as IS1326, IS1327, IS1328, IS1329, and IS1440 [22, 23] , which might serve as epidemiological markers of Y. enterocolitica 1B group. At least some genes of the hypothetical prophage encoded by YPO2273^2279 of Y. pestis CO92 [19] were present in Y. enterocolitica O:3 isolate, while a sequence with similarity to that encoding the Ecs5005 hypothetical protein (encoded by VT2-Sakaj prophage carrying the verotoxin 2 genes) [15] was restricted to Y. enterocolitica O:8 strain.
The same Y. pestis sequences, YPO0466 and YPO2884, encoding hypothetical proteins [19] were presented in subtractive libraries of both strains. Still, YPO0466 sequence showed 77% homology with Y. enterocolitica O:3, but only 49% with Y. enterocolitica O:8 sequence. YPO2884 sequence demonstrated 56% similarity with that revealed in Y. enterocolitica O:3, but only a small fragment of YPO2884 (44 aa) had 65% homology with the sequence from Y. enterocolitica O:8 strain. Moreover, both YPO0446 and YPO2884 showed 77% homology with each other, emphasizing a common origin of both sequences. Thus, subtractive hybridization was able to uncover diverging sequences in two closely related strains of Yersinia.
Taken together, the method of SSH applied to strains of two groups of human pathogenic yersiniae uncovered multiple genomic di¡erences that might be responsible for the observed peculiarities in clinical manifestations of these medically important bacteria and serve as a basis for their ¢ne diagnostics.
